Continuous Glucose Monitoring Improved Glycemic Control in Patients with Type 1 Diabetes in a 52-Week Period, either with Insulin Pump Therapy or with a Basal-Bolus Insulin Regimen

被引：0
|
作者：
Soupal, Jan
Petruzelkova, Lenka
Flekac, Milan
Skrha, Jan, Jr.
Skrha, Jan
Prazny, Martin
机构：
来源：
DIABETES | 2016年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
869-P
引用
收藏
页码：A223 / A223
页数：1
相关论文
共 50 条
  • [31] OPTIMAL REGIMENS OF THE BASAL-BOLUS INSULIN THERAPY IN ADOLESCENTS WITH TYPE 1 DIABETES MELLITUS
    Galkina, G. A.
    Voropay, A. A.
    Levkovich, M. A.
    Vorobiov, S. V.
    Komkova, M. V.
    Morozova, N. V.
    [J]. BYULLETEN SIBIRSKOY MEDITSINY, 2015, 14 (05): : 15 - U223
  • [32] Intensification of insulin therapy in patients with type 2 diabetes mellitus: An algorithm for basal-bolus therapy
    Abrahamson, Martin J.
    Peters, Anne
    [J]. ANNALS OF MEDICINE, 2012, 44 (08) : 836 - 846
  • [33] Comparable Efficacy and Safety of Insulin Glulisine and Insulin Lispro When Given as Part of a Basal-Bolus Insulin Regimen in a 26-Week Trial in Pediatric Patients with Type 1 Diabetes
    Philotheou, Areti
    Arslanian, Silva
    Blatniczky, Laszlo
    Peterkova, Valentina
    Souhami, Elisabeth
    Danne, Thomas
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2011, 13 (03) : 327 - 334
  • [34] Improved Glycemic Control Despite Reductions in Bolus Insulin Doses With Basal Insulin LY2605541 Compared With Basal Insulin Glargine in Patients With Type 1 Diabetes
    Rosenstock, Julio
    Bergenstal, Richard M.
    Blevins, Thomas
    Morrow, Linda
    Qu, Yongming
    Jacober, Scott J.
    [J]. DIABETES, 2013, 62 : A232 - A232
  • [35] LOWER TREATMENT COSTS WITH INSULIN GLARGINE COMPARED TO INSULIN DETEMIR IN TYPE 1 DIABETES PATIENTS TREATED WITH A BASAL-BOLUS REGIMEN IN GERMANY
    Wiesner, T.
    Schaedlich, P. K.
    Dippel, F. W.
    Koltermann, K.
    Hagenmeyer, E. G.
    [J]. VALUE IN HEALTH, 2010, 13 (07) : A294 - A294
  • [36] Glycemic control with the basal/bolus insulin delivery system hPATCH™ measured by continuous glucose monitoring system (CGMS) in patients with type 2 diabetes mellitus
    Strange, Poul
    Kapitza, Christoph
    Schleusener, Debra
    Fein, Seymour
    [J]. DIABETES, 2007, 56 : A121 - A121
  • [37] Stepwise intensification of prandial insulin versus basal-bolus insulin therapy in patients with type 2 diabetes mellitus
    Raccah, D.
    Haak, T.
    Huet, D.
    Monnier, L.
    Ramon, J. S.
    Robertson, D.
    Labard, P.
    Penfornis, A.
    [J]. DIABETOLOGIA, 2010, 53
  • [38] Insulin requirements, basal-bolus distribution and basal patterns used by type 1 diabetic patients (T1DM) starting insulin pump therapy (CSII) and after glucose control optimisation
    Saigi, I.
    Tundidor, D.
    Jordana, L.
    Maria, M. A.
    Corcoy, R.
    Chico, A.
    [J]. DIABETOLOGIA, 2010, 53
  • [39] Two-way crossover comparison of insulin glargine and insulin detemir in basal-bolus therapy using continuous glucose monitoring
    Abe, Shinya
    Inoue, Gaku
    Yamada, Satoru
    Irie, Junichiro
    Nojima, Hiroyuki
    Tsuyusaki, Kaoru
    Usui, Kensuke
    Atsuda, Koichiro
    Yamanouchi, Toshikazu
    [J]. DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2011, 4 : 283 - 288
  • [40] Reduced Mean Glucose and Glycemic Variability with Coadministration of Basal-Bolus Pramlintide and Insulin in Type 1 Diabetes (T1D)
    Riddle, Matthew C.
    Nahra, Rajaa
    Han, Jenny
    Hompesch, Marcus
    Huffman, David
    Strange, Poul
    Ohman, Peter
    [J]. DIABETES, 2017, 66 : A298 - A298
12345